… IG McKeith has received sponsorship and research grants from Novartis, Pfizer/Eisai, …
Aarsland D, Mosimann UP, McKeith IG. Role of cholinesterase inhibitors in Parkinson's disease …

Recent neuropathologic autopsy studies found that 15 to 25% of elderly demented patients
have Lewy bodies (LB) in their brainstem and cortex, and in hospital series this may …

The Dementia with Lewy Bodies (DLB) Consortium has refined its recommendations about
the clinical and pathologic diagnosis of DLB, updating the previous report, which has been in …

A preceding article described the clinical features of Parkinson's disease dementia (PD‐D)
and proposed clinical diagnostic criteria for “probable” and “possible” PD‐D. The main focus …

The aim of this international guideline on dementia was to present a peer‐reviewed
evidence‐based statement for the guidance of practice for clinical neurologists, geriatricians, …

Background/Objective: The second International Workshop of the Consortium on Dementia
with Lewy Bodies (DLB) met to review developments since publication of consensus …

… its clinical diagnoses of Alzheimer’s disease and DLB against autopsy (McKeith et al, 2000).
… Reading PJ, Luce AK, McKeith IG. Rivastigmine in the treatment of parkinsonian psychosis …

For more than a decade, researchers have refined criteria for the diagnosis of dementia with
Lewy bodies (DLB) and at the same time have recognized that cognitive impairment and …

… IG McKeith / Consensus guidelines for the clinical and pathologic diagnosis of dementia …
IG McKeith / Consensus guidelines for the clinical and pathologic diagnosis of dementia with …

Objective: To determine the validity of a clinical diagnosis of probable or possible dementia
with Lewy bodies (DLB) made using International Consensus criteria. Background: …